Innovodigm’s Big Break: Rs 5.5 Crore Seed Funding to Reinvent Vaccine Delivery
Medtech startup Innovodigm has just secured a seed round of Rs 5.5 crore, marking a significant milestone in its mission to transform how vaccines are delivered. Here’s the full scoop on who backed them, what they’re building, and why it really matters.
Who Invested in Innovodigm?
Indian Angel Network…
Ahammune Biosciences, an innovative biotech firm focused on dermatological therapies, has successfully raised $5 million in a Series A funding round led by the early-stage venture capital firm pi Ventures. This funding round also welcomed participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, along with existing investors such as Ideaspring Capital, Kotak Alternate…
Pune-based biotech startup Ahammune Biosciences has successfully raised $5 million in Series A funding, led by pi Ventures, to further its mission of developing innovative treatments for skin diseases. Other participants in the funding round included Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, and existing investors such as Ideaspring Capital, Kotak Alternate Assets, Legacy…
